Year: 2019
Type: article
Abstract: Rapid advances in DNA sequencing technology ("next-generation sequencing") have inspired optimism about the future potential of human genomics for "precision medicine."Meanwhile, pathogen genomics is already delivering "precision public health" via more effective foodborne illness outbreak investigations, better targeted tuberculosis control, and more timely and granular influenza surveillance to inform vaccine strain selection.In this article, we describe how public health agencies are rapidly adopting pathogen genomics to improve their effectiveness in almost all domains of infectious disease.This momentum is likely to continue, given ongoing development in sequencing and sequencing-related technologies.An important transformation is underway in public health.Next-generation sequencing (NGS, also called "high-throughput sequencing") is reshaping communicable disease surveillance, allowing for earlier detection and more precise investigation of outbreaks.NGS helps characterize microbes more effectively and offers new insights into their ecology and
Source: New England Journal of Medicine
Institutions: Centers for Disease Control and Prevention, New York State Department of Health, Wadsworth Center, National Center for Immunization and Respiratory Diseases, National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Center for Global Health, Centers for Disease Control and Prevention, Centers for Disease Control and Prevention
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: bronze
Funder: National Institutes of Health
Award: G7543494365
OpenAlex ID: W2997069256
